Allograft for Myeloma: Examining Pieces of the Jigsaw Puzzle
Multiple myeloma (MM) cure remains elusive despite the availability of newer anti-myeloma agents. Patients with high-risk disease often suffer from early relapse and short survival. Allogeneic hematopoietic cell transplantation (allo-HCT) is an “immune-based” therapy that has the potential to offer...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Frontiers Media S.A.
2017-12-01
|
| Серія: | Frontiers in Oncology |
| Предмети: | |
| Онлайн доступ: | http://journal.frontiersin.org/article/10.3389/fonc.2017.00287/full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|